Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Future Oncology (London, England)|May 16, 2020
Outcomes of retreatment with anti-PD-1 monotherapy after response to first course in patients with cutaneous melanomaEric D Whitman, Emilie Scherrer, Wanmei Ou, et al.Medicine|July 27, 2019
Real-world experience with pembrolizumab in patients with advanced melanoma: A large retrospective observational studyFrank Xiaoqing Liu, Wanmei Ou, Scott J Diede, et al.JRSM Open|July 25, 2014
Variations in time to receiving first surgical treatment for breast cancer as a function of racial/ethnic background: a cohort studyRami T Bustami, Daniel B Shulkin, Nancy O'Donnell, et al.Journal of Surgical Oncology|March 17, 2012
Role of sentinel lymphadenectomy in thin cutaneous melanomas with positive deep margins on initial biopsyVadim P Koshenkov, Daniel Shulkin, Rami Bustami, et al.Future Oncology (London, England)|September 26, 2018
Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practicesEric D Whitman, Frank Xiaoqing Liu, Xiting Cao, et al.BMC Cancer|March 28, 2024
Assessing the use of anti-PD1 monotherapy as adjuvant therapy and determinants of treatment choice in stage III cutaneous melanoma in the USEric D Whitman, Todor I Totev, Shan Jiang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2021
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable MelanomaRobert H I Andtbacka, Brendan Curti, Gregory A Daniels, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 StudyTheresa Medina, Jason A Chesney, Harriet M Kluger, et al.Immunity|October 31, 2020
Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike ProteinAndrew P Ferretti, Tomasz Kula, Yifan Wang, et al.The Lancet. Infectious Diseases|March 14, 2022
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 studyJames Welker, Juan D Pulido, Andrew T Catanzaro, et al.Pageof 2